Sysmex Co. (OTCMKTS:SSMXY) Sees Large Decrease in Short Interest

Sysmex Co. (OTCMKTS:SSMXY) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,000 shares, a drop of 66.7% from the February 28th total of 3,000 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 109,300 shares, the days-to-cover ratio is presently 0.0 days.

Sysmex Stock Performance

Shares of OTCMKTS SSMXY traded down $0.30 during trading on Friday, reaching $18.85. 58,485 shares of the company traded hands, compared to its average volume of 67,435. The stock has a market cap of $11.87 billion, a P/E ratio of 36.87 and a beta of 0.88. Sysmex has a 12-month low of $14.38 and a 12-month high of $28.32. The firm’s fifty day simple moving average is $18.61 and its 200 day simple moving average is $19.10. The company has a current ratio of 3.19, a quick ratio of 2.42 and a debt-to-equity ratio of 0.11.

Sysmex (OTCMKTS:SSMXY) last posted its earnings results on Wednesday, February 12th. The company reported $0.17 earnings per share (EPS) for the quarter. As a group, research analysts anticipate that Sysmex will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.